Current Oncology · 2015 · 18 citations · 15 references
Life SciencesGeneticsOncologyCancer GeneticsHuman GeneticsMedical GeneticsCancer RiskFamilial Cancer AggregationGenetic Risk AssessmentGermline Cancer SusceptibilityHereditary Cancer SyndromesMalignant NeoplasmsFamilial Cancer RiskFamilial Cancer SyndromesFamily History Of CancerFamily History-based ScreeningHereditary Cancer RiskInherited Cancer RiskInherited Cancer SusceptibilityLi-fraumeni Syndrome
BACKGROUND: Sarcomas in adults can be associated with hereditary cancer syndromes characterized by early-onset predisposition to numerous types of cancer. Because of variability in familial presentation and the largely unexplained genetic basis of sarcomas, ascertainment of patients for whom a genetics evaluation is most indicated poses challenges. We assessed the utility of a Sarcoma Clinic Genetic Screening (scgs) questionnaire in facilitating that task. METHODS: Between 2008 and 2012, 169 patients (median age: 53 years; range: 17-88 years) completed a self-administered scgs questionnaire. A retrospective chart review was completed for all respondents, and descriptive statistics were reported. Probands were divided into two groups depending on whether they did or did not report a family history of Li-Fraumeni syndrome-type cancers. RESULTS: A family history of cancer (as far as 3rd-degree relatives) was reported in 113 of 163 sarcoma patients (69%). Eeles Li-Fraumeni-like (lfl) criteria were fulfilled in 46 probands (28%), Chompret lfl in 21 (13%), Birch lfl in 8 (5%), and classic Li-Fraumeni in none. In the 10 probands tested for TP53 mutations, 1 pathogenic mutation was found. Further investigation of selected families led to the discovery of germline mutations in MLH1, MSH2, and APC genes in 3 individuals. CONCLUSIONS: The scgs questionnaire was useful for ascertaining probands with sarcoma who could benefit from a genetic assessment. The tool allowed us to identify high-risk families fitting the criteria for lfl and, surprisingly, other hereditary cancer syndromes. Similar questionnaires could be used in other cancer-specific clinics to increase awareness of the genetic component of these cancers.
15
A cancer family syndrome in twenty-four kindreds.
Frederick P. Li, Joseph F. Fraumeni, J. J. Mulvihill et al. · PubMed · 1988 · 1.3K citations
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
Birch, Hartley, Tricker et al. · Cancer Research · 1994 · 478 citations
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
John Birch, Alison Condie, AM Kelsey et al. · PubMed · 1994 · 425 citations
Life Sciences, Genetics, Oncology +17
Tumors associated with p53 germline mutations: a synopsis of 91 families.
Paul Kleihues, Barbara Schäuble, Axel zur Hausen et al. · PubMed · 1997 · 414 citations
Life Sciences, Genetics, Oncology +12